View Document Preview and Link Document Date: 2009-12-08 04:25:30 Open Document File Size: 216,50 KB Share Result on Facebook
City Hyderabad / / Company Aurobindo Pharma Ltd. / Lamivudine Oral Solution (10 mg/mL) Aurobindo Pharma Ltd. / / Country United States / India / / Facility store Lamivudine Oral Solution / STORING LAMIVUDINE ORAL SOLUTION Store / / IndustryTerm drug product / manufacturing practices / HIV therapy / food / HIV treatment / active pharmaceutical ingredient / treatment of HIV / manufacturing quality standards / manufacturing / / MedicalCondition HIV / headache / serious liver disease / stomach pain / coma / nausea / skin rash / severe anemia / numbness / fatigue / drowsiness / muscle disorders / diarrhea / hepatitis / tiredness / liver disease / infections / HIV infection / abdominal pain / insomnia / opportunistic infections / disease / kidney disease / advanced HIV infection / neutropenia / diabetes / hyperlipidemia / fever / vomiting / lactic acidosis / Virus (HIV) infection / opportunistic infection / Diabetes Mellitus / AIDS / HIV/AIDS / irritation / infection / cough / inflammation / joint pain / chronic Hepatitis B / anemia / HIV disease / dehydration / / MedicalTreatment antiretroviral therapy / / Organization World Health Organization / United Nations / U. S. Food and Drug Administration / FDA / / / Position President / pharmacist / / Product Lamivudine / / ProvinceOrState Andhra Pradesh / / Technology diagnostic tests / API / / SocialTag 
FDA Tentative Approval November 8, 2005 Lamivudine Oral Solution (10 mg/mL) Aurobindo Pharma, Ltd. 1